» Articles » PMID: 37116154

Genotyping and Phylogenetic Analysis of Human Papillomaviruses in Formalin Fixed Paraffin Embedded Sections from Cervical Lesions in Duhok-Iraq

Overview
Specialty Oncology
Date 2023 Apr 28
PMID 37116154
Authors
Affiliations
Soon will be listed here.
Abstract

Objective: Human papillomavirus (HPV) has been identified as an important causative factor in cervical cancer development. Cervical cancer is the fourth most prevalent malignant tumor among women globally. The purpose of this study was to investigate the prevalence and genotyping sequences of HPV in formalin-fixed paraffin-embedded (FFPE) cervical tissue using conventional polymerase chain reaction (PCR), and HPV-DNA sequencing.

Material And Methods: Retrospective cross-sectional study. Forty (FFPE) blocks with different cervical lesions were taken; patients' ages ranged from 24 to 65 years. Detection and sequencing of HPV DNA were done by conventional PCR (L1 gene), which was achieved by universal PCR primers (MY09/11 oligonucleotides). Then sequencing and phylogenetic tree was constructed.

Results: Nine samples were found positive and detected by conventional PCR, they were identified in CIN1 and SCC at 7.5% (n=3) for each, 5.0% (n=2) KA, and 2.5% (n=1) in CIN3 cases, after sequencing were submitted to GenBank and accession numbers were obtained. The phylogenetic tree was constructed and the aligned sequences showed high homology with the nucleotide sequence of the references from the Genbank database. HPV 11, 16, 18, 22, 33, 52, and 58 were found to have little nucleotide heterogeneity and thus no amino acid heterogeneity.  Conclusion: Sequencing and  phylogenetic analysis of circulating HPV types in Duhok provides very essential data about nucleotides and amino acid heterogeneity, to reveal genetic diversity with strains included in the vaccines that have not been introduced to Iraq yet.

Citing Articles

Distribution of HPV Types in Cervical Cancer in Pakistan: Implications for Screening and Vaccination Programs.

Aziz H, Mehmood H, Arif S, Afzal K, Hanif S, Saeed M J Clin Lab Anal. 2024; 39(1):e25130.

PMID: 39639577 PMC: 11737109. DOI: 10.1002/jcla.25130.

References
1.
Pity I, Abdo H, Goreal A . Human Papillomavirus Genotyping among Different Cervical Smears in Duhok/Iraq. Asian Pac J Cancer Prev. 2019; 20(7):2059-2064. PMC: 6745234. DOI: 10.31557/APJCP.2019.20.7.2059. View

2.
Liao Y, Li Q . Profile of MeltPro® HPV test for human papillomavirus genotyping and cervical precancer screening. Expert Rev Mol Diagn. 2019; 19(10):857-862. DOI: 10.1080/14737159.2019.1662299. View

3.
Garbuglia A, Lapa D, Sias C, Capobianchi M, Del Porto P . The Use of Both Therapeutic and Prophylactic Vaccines in the Therapy of Papillomavirus Disease. Front Immunol. 2020; 11:188. PMC: 7040023. DOI: 10.3389/fimmu.2020.00188. View

4.
Muderris T, Afsar I, Yildiz A, Akpinar Varer C . HPV genotype distribution among women with normal and abnormal cervical cytology in Turkey. Rev Esp Quimioter. 2019; 32(6):516-524. PMC: 6913072. View

5.
Depuydt C, Boulet G, Horvath C, Benoy I, Vereecken A, Bogers J . Comparison of MY09/11 consensus PCR and type-specific PCRs in the detection of oncogenic HPV types. J Cell Mol Med. 2007; 11(4):881-91. PMC: 3823264. DOI: 10.1111/j.1582-4934.2007.00073.x. View